United Therapeutics Corp (UTHR)
297.06
+9.00
(+3.12%)
USD |
NASDAQ |
Jun 17, 16:00
297.02
-0.04
(-0.02%)
Pre-Market: 20:00
United Therapeutics Profit Margin (Quarterly): 45.24% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 45.24% |
| December 31, 2023 | 35.32% |
| September 30, 2023 | 43.91% |
| June 30, 2023 | 43.45% |
| March 31, 2023 | 47.52% |
| December 31, 2022 | 26.88% |
| September 30, 2022 | 46.38% |
| June 30, 2022 | 24.84% |
| March 31, 2022 | 51.94% |
| December 31, 2021 | 27.02% |
| September 30, 2021 | 36.59% |
| June 30, 2021 | 38.66% |
| March 31, 2021 | 7.46% |
| December 31, 2020 | 25.67% |
| September 30, 2020 | 45.04% |
| June 30, 2020 | 29.59% |
| March 31, 2020 | 38.65% |
| December 31, 2019 | 16.91% |
| September 30, 2019 | 32.98% |
| June 30, 2019 | 54.90% |
| March 31, 2019 | -136.4% |
| December 31, 2018 | 17.12% |
| September 30, 2018 | 25.81% |
| June 30, 2018 | 38.90% |
| March 31, 2018 | 62.82% |
| Date | Value |
|---|---|
| December 31, 2017 | 4.09% |
| September 30, 2017 | 62.02% |
| June 30, 2017 | -12.60% |
| March 31, 2017 | 48.21% |
| December 31, 2016 | 26.97% |
| September 30, 2016 | 39.64% |
| June 30, 2016 | 49.95% |
| March 31, 2016 | 63.82% |
| December 31, 2015 | 25.83% |
| September 30, 2015 | |
| June 30, 2015 | 28.57% |
| March 31, 2015 | -5.07% |
| December 31, 2014 | 33.48% |
| September 30, 2014 | -7.65% |
| June 30, 2014 | 34.65% |
| March 31, 2014 | 47.52% |
| December 31, 2013 | -10.49% |
| September 30, 2013 | 20.74% |
| June 30, 2013 | 28.46% |
| March 31, 2013 | 25.42% |
| December 31, 2012 | 34.15% |
| September 30, 2012 | 32.22% |
| June 30, 2012 | 32.06% |
| March 31, 2012 | 34.65% |
| December 31, 2011 | 22.13% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
7.46%
Minimum
Mar 2021
54.90%
Maximum
Jun 2019
35.95%
Average
37.62%
Median
Profit Margin (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | -- |
| Liquidia Corp | -1.38K% |
| Vertex Pharmaceuticals Inc | 40.87% |
| ANI Pharmaceuticals Inc | 13.25% |
| Ionis Pharmaceuticals Inc | -119.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.05% |
| Return on Assets | 15.58% |
| Return on Invested Capital | 16.80% |
| Gross Profit Margin (Quarterly) | 89.24% |
| Operating Margin (Quarterly) | 52.57% |
| Return on Net Operating Assets | 73.94% |